69 related articles for article (PubMed ID: 24803308)
21. Aspirin and urinary 11-dehydrothromboxane B(2) in African American stroke patients.
Bruno A; McConnell JP; Mansbach HH; Cohen SN; Tietjen GE; Bang NU
Stroke; 2002 Jan; 33(1):57-60. PubMed ID: 11779889
[TBL] [Abstract][Full Text] [Related]
22. The inhibitory effect of statins on urinary 11-dehydrothromboxane levels.
Alusik S; Paluch Z; Lejsková M; Adámek T
Int Angiol; 2010 Jun; 29(3):255-9. PubMed ID: 20502413
[TBL] [Abstract][Full Text] [Related]
23. Thromboxane and prostacyclin biosynthesis in patients with acute spontaneous intracerebral hemorrhage.
Saloheimo P; Juvela S; Riutta A; Pyhtinen J; Hillbom M
Thromb Res; 2005; 115(5):367-73. PubMed ID: 15733969
[TBL] [Abstract][Full Text] [Related]
24. beta-Thromboglobulin and 11-dehydrothromboxane B in tension-type headache.
Oishi M; Mochizuki Y
Headache; 1998 Oct; 38(9):676-8. PubMed ID: 15613179
[TBL] [Abstract][Full Text] [Related]
25. Analysis of 11-dehydrothromboxane B2 in human urine improved by use of gas chromatography/high-resolution selected ion monitoring with 18O2-labelled analogue as an internal standard.
Ishibashi M; Nakagawa Y; Harima N; Hishinuma T; Mizugaki M
Biol Mass Spectrom; 1994 Oct; 23(10):612-20. PubMed ID: 7986831
[TBL] [Abstract][Full Text] [Related]
26. Predictors of high platelet reactivity during aspirin treatment in patients with type 2 diabetes.
Kapłon-Cieślicka A; Rosiak M; Postuła M; Serafin A; Kondracka A; Opolski G; Filipiak KJ
Kardiol Pol; 2013; 71(9):893-902. PubMed ID: 24065375
[TBL] [Abstract][Full Text] [Related]
27. Response to aspirin in healthy individuals. Cross-comparison of light transmission aggregometry, VerifyNow system, platelet count drop, thromboelastography (TEG) and urinary 11-dehydrothromboxane B(2).
Blais N; Pharand C; Lordkipanidzé M; Sia YK; Merhi Y; Diodati JG
Thromb Haemost; 2009 Aug; 102(2):404-11. PubMed ID: 19652893
[TBL] [Abstract][Full Text] [Related]
28. [Elevation of 11-dehydro-thromboxane B2 levels in unstable angina].
Koike T; Hattori A; Igarashi Y; Matsubara T; Tamura Y; Yamazoe M; Izumi T; Shibata A
J Cardiol; 1991; 21(4):899-904. PubMed ID: 1844445
[TBL] [Abstract][Full Text] [Related]
29. Identification of 11-dehydrothromboxane B3 in human urine after administration of eicosapentaenoic acid.
Ishibashi M; Ohyama Y; Mizugaki M; Harima N
Biomed Environ Mass Spectrom; 1990 Jun; 19(6):387-9. PubMed ID: 2357490
[No Abstract] [Full Text] [Related]
30. Reduced blood platelet sensitivity to aspirin in coronary artery disease: are dyslipidaemia and inflammatory states possible factors predisposing to sub-optimal platelet response to aspirin?
Markuszewski L; Rosiak M; Golanski J; Rysz J; Spychalska M; Watala C
Basic Clin Pharmacol Toxicol; 2006 May; 98(5):503-9. PubMed ID: 16635110
[TBL] [Abstract][Full Text] [Related]
31. Factors affecting the reliability of direct radioimmunoassay for urinary 11-dehydrothromboxane B2 with 125I-labelled ligand: albumin and heterogeneous immunoreactivity.
Mucha I; Riutta A; Vapaatalo H
Eicosanoids; 1991; 4(1):1-7. PubMed ID: 2059455
[TBL] [Abstract][Full Text] [Related]
32. Radioimmunoassay of 11-dehydrothromboxane B2.
Ciabattoni G; Patrignani P; Patrono C
Methods Enzymol; 1990; 187():34-42. PubMed ID: 2233352
[No Abstract] [Full Text] [Related]
33. A comparison of VerifyNowR with PlateletMappingR--detected aspirin resistance and correlation with urinary thromboxane.
Carroll RC; Craft RM; Snider CC; Aligeti VR; Wortham DC
Anesth Analg; 2013 Feb; 116(2):282-6. PubMed ID: 23302970
[TBL] [Abstract][Full Text] [Related]
34. Dimethylisopropylsilyl ether derivative in gas chromatography/mass spectrometry of 11-dehydrothromboxane B2.
Ishibashi M; Watanabe K; Harima N; Krolik S
Biomed Environ Mass Spectrom; 1988 Aug; 17(2):133-5. PubMed ID: 3191252
[No Abstract] [Full Text] [Related]
35. Laropiprant in combination with extended-release niacin does not alter urine 11-dehydrothromboxane B2, a marker of in vivo platelet function, in healthy, hypercholesterolemic, and diabetic subjects.
Lauring B; Dishy V; Luo WL; Laterza O; Patterson J; Cote J; Chao A; Larson P; Gutierrez M; Wagner JA; Lai E
J Clin Pharmacol; 2009 Dec; 49(12):1426-35. PubMed ID: 19833861
[TBL] [Abstract][Full Text] [Related]
36. Aspirin resistance in children with heart disease at risk for thromboembolism: prevalence and possible mechanisms.
Heistein LC; Scott WA; Zellers TM; Fixler DE; Ramaciotti C; Journeycake JM; Lemler MS
Pediatr Cardiol; 2008 Mar; 29(2):285-91. PubMed ID: 17896127
[TBL] [Abstract][Full Text] [Related]
37. The purification step is not crucial in EIA measurements of thromboxane B2 and 11-dehydrothromboxane B2 in human plasma.
Sadilkova L; Paluch Z; Mottlova J; Bednar F; Alusik S
Clin Lab; 2012; 58(1-2):177-83. PubMed ID: 22372363
[TBL] [Abstract][Full Text] [Related]
38. Dibutyryl cAMP effects on thromboxane and leukotriene production in decompression-induced lung injury.
Little TM; Butler BD
Undersea Hyperb Med; 1997 Sep; 24(3):185-91. PubMed ID: 9308142
[TBL] [Abstract][Full Text] [Related]
39. Urinary excretion of leukotriene E4 and 11-dehydro-thromboxane B2 in response to bronchial provocations with allergen, aspirin, leukotriene D4, and histamine in asthmatics.
Kumlin M; Dahlén B; Björck T; Zetterström O; Granström E; Dahlén SE
Am Rev Respir Dis; 1992 Jul; 146(1):96-103. PubMed ID: 1320824
[TBL] [Abstract][Full Text] [Related]
40. Statin therapy and thromboxane generation in patients with coronary artery disease treated with high-dose aspirin.
Bliden KP; Singla A; Gesheff MG; Toth PP; Tabrizchi A; Ens G; Guyer K; Singh M; Franzese CJ; Stapleton D; Tantry US; Gurbel PA
Thromb Haemost; 2014 Aug; 112(2):323-31. PubMed ID: 24763965
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
